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Background: Small bowel obstruction is a common surgical emergency, and is associated with high
levels of morbidity and mortality across the world. The literature provides little information on the
conservatively managed group. The aim of this study was to describe the burden of small bowel
obstruction in the UK.
Methods: This prospective cohort study was conducted in 131 acute hospitals in the UK between January
and April 2017, delivered by trainee research collaboratives. Adult patients with a diagnosis of mechanical
small bowel obstruction were included. The primary outcome was in-hospital mortality. Secondary
outcomes included complications, unplanned intensive care admission and readmission within 30 days
of discharge. Practice measures, including use of radiological investigations, water soluble contrast,
operative and nutritional interventions, were collected.
Results: Of 2341 patients identified, 693 (29⋅6 per cent) underwent immediate surgery (within 24h
of admission), 500 (21⋅4 per cent) had delayed surgery after initial conservative management, and 1148
(49⋅0 per cent) were managed non-operatively. The mortality rate was 6⋅6 per cent (6⋅4 per cent
for non-operative management, 6⋅8 per cent for immediate surgery, 6⋅8 per cent for delayed surgery;
P= 0⋅911). Themajor complication rate was 14⋅4 per cent overall, affecting 19⋅0 per cent in the immediate
surgery, 23⋅6 per cent in the delayed surgery and 7⋅7 per cent in the non-operative management groups
(P< 0⋅001). Cox regression found hernia or malignant aetiology and malnutrition to be associated with
higher rates of death. Malignant aetiology, operative intervention, acute kidney injury and malnutrition
were associated with increased risk of major complication.
Conclusion: Small bowel obstruction represents a significant healthcare burden. Patient-level factors
such as timing of surgery, acute kidney injury and nutritional status are factors that might be modified
to improve outcomes.
∗Members of the NASBO steering group and NASBO collaborators are co-authors of this study and are listed in
Appendices S1 and S2 (supporting information)
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Introduction
Small bowel obstruction (SBO) is a common surgical
condition, accounting for 50 per cent of emergency
laparotomies each year in the UK1 and over 300 000
admissions annually in the USA2. It is common in low-
and middle-income countries, accounting for 1⋅8 deaths
per 100 000 population per year3. The condition is associ-
ated with a mortality rate of approximately 10 per cent and
high rates of morbidity among survivors4,5. The causes of
SBO are diverse, and, depending on suspected cause and
patient factors, surgery may be indicated. SBO interrupts
enteral feeding and gut homeostasis. In the absence of
bowel ischaemia, a trial of non-operative management
may be adopted, with the option of delayed surgery in
patients whose obstruction typically fails to resolve within
2 days. Longer periods of conservative management may
be attempted for patients with adhesional obstruction
or in patients with co-morbidities who are considered
initially unsuitable for operative management6. Surgery
may involve resection of non-viable intestine7,8.
There is global attention on outcomes in emergency
surgery9. The USA has taken steps to improve outcomes
through the National Surgical Quality Improvement Pro-
gram (NSQIP). This primarily captures data on patients
undergoing surgical procedures and lacks information
on the large cohort managed by emergency general sur-
geons without surgical intervention10. The UK National
Emergency Laparotomy Audit (NELA)1 focused on
improving standards of care for patients undergoing
emergency laparotomy, and provides information on
timing of diagnostics, assessments, interventions and out-
comes. It also lacks information on the group who do not
undergo surgery. Identification of patient groups where
non-operative management is unlikely to be successful,
and outcomes from conservative management of SBO have
been poorly studied to date. Better data on management of
patients with SBO is needed to determine current practice,
define outcomes across the condition and identify areas
where care may be improved.
The aims of this study were to establish current practice
in the management of patients admitted acutely with SBO,
describe outcomes following treatment and identify clinical
factors associated with poor outcome.
Methods
This study was conducted in line with a predefined
protocol11, and reported in line with STROBE12 and
SAMPL13 guidelines.
Public and patient involvement
This study was conceived based on public and patient
research priority setting by the Association of Coloproctol-
ogy of Great Britain and Ireland14. A patient representative
identified through the Bowel Disease Research Founda-
tion provided feedback and input on study design, attended
all steering group meetings, and advised on interpretation
of findings. The patient representative was involved in the
preparation of this manuscript and is a co-author.
Funding and role of funders
Funding and non-financial support was received from
the Bowel Disease Research Foundation, Association
of Surgeons of Great Britain and Ireland, Association
of Coloproctology of Great Britain and Ireland, Associa-
tion of Upper Gastrointestinal Surgeons, British Associa-
tion for Parenteral and Enteral Nutrition, British Society
of Gastroenterology, Royal College of Surgeons of Eng-
land, Royal College of Surgeons of Edinburgh, Royal
College of Anaesthetists, British Association for Surgical
Oncology and National Emergency Laparotomy Audit
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during the conduct of the study. Funding bodies provided
financial support for administrative and statistical support,
and for dissemination materials. As all funders had dual
roles as specialty associations, Royal Colleges or charities,
they were invited to have representation on the steering
group. Analysis and sharing of findings was undertaken
independently of the funding bodies.
Transparency
This manuscript is an honest, accurate and transparent
account of the study being reported. No important aspects
of the study have been omitted, and any discrepancies from
the study as originally planned have been explained. M.J.L.
and N.S.F. are guarantors.
Research collaborative network
TheNational Audit of Small Bowel Obstruction (NASBO)
was designed and delivered by surgical trainee research
collaboratives15 with the support of Royal Colleges, pro-
fessional specialty associations and the Bowel Disease
Research Foundation. NASBO was established to pro-
vide prospectively determined high-quality information on
patients treated for mechanical SBO of all causes, includ-
ing non-operative management, use of diagnostic tools and
supportive strategies including nutrition.
Collaborators provided input into the design, including
conducting the pilot study, data collection and validation,
and review of final manuscript before submission. Each
participating site included oversight by a designated con-
sultant surgeon, with data collection undertaken by trainee
surgeons or allied health professionals. An independent
teammember who was not involved in primary data collec-
tion undertook a validation exercise. Roles are presented in
Appendix S3 (supporting information), in line with trainee
research collaborative principles16.
Ethical approval and governance
Assessment by the South-East Scotland Research
and Ethics committee confirmed that this study did not
require ethical approval (reference NR/1610AB10). Sites
secured local audit and Caldicott Guardian permissions
to participate and were not permitted to collect data with-
out confirmation of approvals. The audit was registered
with the Healthcare Quality Improvement Partnership.
Patient identification and eligibility
All UK-based sites offering emergency surgery were eli-
gible to participate in this study, and invited through
targeted e-mails from specialty associations and through
social media. The audit also appeared on the Health-
care Quality Improvement Partnership database, and some
sites enrolled proactively. Patients were identified across
an 8-week period from 16 January to 13 March 2017
and followed up for 30 days after discharge. Patients were
screened for eligibility at referral to the surgical team.
Patients were eligible for inclusion in the study if they had a
diagnosis of SBO and were aged 18 years or older. A clinical
diagnosis of SBO had to be made or confirmed by a con-
sultant or a specialty trainee with 3 or more years of post-
graduate surgical experience. Patients subsequently found
to have non-mechanical SBO, left colonic obstruction caus-
ing SBO, or who were managed with palliative intent from
the time of admission were excluded from analysis.
Data and definitions
Data on route of referral to the surgical team, baseline
demographics (age, sex, height, weight), co-morbidity
(Charlson Co-morbidity Index, CCI17) and admission
parameters (such as presence of acute kidney injury (AKI),
white cell count) were captured. The time spent nil by
mouth before referral, and duration of any preceding hos-
pital stay (for example, on a medical ward before referral)
was documented. Use and timing of abdominal radio-
graphy, CT and use of water-soluble contrast agents were
recorded. Data on operative interventions included timing,
approach and key components of the operation (such as
small bowel resection, stoma formation). Nutritional data,
including BMI, interval between last and reintroduction of
enteral nutrition, and use of nutritional support interven-
tions, were recorded. Nutritional Risk Index (NRI) was
calculated using ideal bodyweight, current bodyweight and
admission albumin level.
Data were entered into a secure, fully audited REDCap
database18 housed at theUniversity of Sheffield. All records
were pseudo-anonymized, and accessible only to the local
team and research team database administrators.
Patients were classified into three treatment groups: an
immediate surgery group, where a decision to operate was
made within 24 h of surgical review; a delayed surgery
group that included patients who were managed initially
with non-operative intent but subsequently required sur-
gical intervention; and a non-operative group comprising
patients who did not undergo surgery at any time point.
Outcomes
The primary outcome was in-hospital mortality. Secondary
outcomes included a composite of major complications
(in-hospital mortality, unplanned intensive care admission,
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30-day readmissions), pneumonia, cardiac complications
and surgical-site infections. The case report form is pre-
sented in Appendix S4 (supporting information). Defini-
tions of recorded outcomes are available in Appendix S5
(supporting information).
Validation
To ensure data accuracy and case ascertainment, validation
of key fields of 25 per cent of all patient records was under-
taken by an independent investigator at each site who had
not been involved in primary data collection. Records were
identified for sampling by using a random number gener-
ator at the coordinating site, and validation was completed
within a predetermined 30-day time window. Categorical
fields were deemed accurate when there was exact agree-
ment between responses. Continuous variables were con-
sidered accurate with a perfect match, or rounding error
of less than 0⋅5 of the reported value. Unit data were
excluded if the validation process was incomplete. Accuracy
was calculated as a percentage of matching fields in each
record.
Statistical analysis
A sample of the population over 8weeks was planned.
Using data from a 2-week pilot in eight hospitals, it was
anticipated that 80 hospitals would generate a sample size
of 2000 patients, with which it would be possible to detect a
difference in primary outcomes from 5 to 10 per cent at 99
per cent power with an α value of 0⋅050, with an allocation
ratio of 1 : 3 between immediate surgery, delayed surgery
and non-operative groups. It was conducted in line with the
published protocol11.
For the outcomes survival and complications, models
were constructed to adjust for clinically plausible variables,
including age, CCI19 and theNRI20. CCI scores were strat-
ified into no comorbidity (0), mild co-morbidity (1–10)
and significant comorbidity (11 and over). NRI was catego-
rized into low (more than 97⋅5), moderate (83⋅5–97⋅5) and
high (below 83⋅5) risk. For survival analyses, Cox propor-
tional hazards models were constructed to adjust for clini-
cally plausible variables.Models were clustered by centre to
adjust for hospital-level effects. Effect sizes are presented as
hazards ratios (HRs) with 95 per cent confidence intervals.
For the binary outcomes in-hospital complications and
30-day readmission, multilevel mixed-effects logistic
regression models were constructed to adjust for
patient-level (level 1 fixed effects) and hospital-level (level
2 random effects) factors. Effect sizes for these models are
presented as odds ratios (ORs) with 95 per cent confidence
intervals. Model fit was guided by clinical plausibility, the
Patients entered into
REDCap database
n= 2604
Patients assessed by
steering group
n= 2452
Excluded n= 111
 Not eligible based on diagnosis n= 18
 Missing outcome data n= 20
 Managed with palliative intent n= 73
Excluded following
diagnostic test results
n= 152
Patients included in
analysis
n= 2341
Fig. 1 Flow chart showing identification of patients for analysis
Akaike information criterion and goodness of fit (measured
using adjusted R2). To investigate the relationship between
time to surgery and mortality, adjusted binary logistic
regression was used to predict the risk of death, which was
subsequently plotted against time to surgery in the form of
a restricted cubic spline. To provide more information on
the effects of co-morbidities and age, splines were stratified
by age and CCI. For all tests, statistical significance was
set at P≤ 0⋅050 a priori. All analyses were performed in
R version 3.3.2 (R Foundation for Statistical Computing,
Vienna, Austria), using the finalfit, lme4, survival, splines
and tidyverse packages.
Results
A total of 2604 patients from 131 hospitals were entered
into the study; 152 patients were subsequently excluded
by collaborators following diagnostic test results. Before
statistical analysis, 18 records were excluded as they did not
meet the study inclusion criteria and a further 20 records
were excluded owing to missing outcome data. As this ana-
lysis focused on outcomes following treatment with cura-
tive intent, data on 73 patients who received end-of-life
care were excluded, leaving 2341 patients in the analysis
(Fig. 1). The independent validation study confirmed data
accuracy at 92⋅4 per cent.
Patient demographics and characteristics
Patients included in the final analysis had a mean(s.d.) age
of 67⋅1(16⋅9) years and 54⋅8 per cent were women. The
mean CCI score was 3⋅4(6⋅2). Characteristics according
to management strategy are presented in Table 1 and a
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Table 1 Patient characteristics
Non-operative
(n=1148)
Immediate surgery
(n=693)
Delayed surgery
(n=500) P†
Age at admission to study (years)* 66⋅9(16⋅9) 67⋅4(16⋅5) 67⋅1(17⋅4) 0⋅738‡
Sex M 541 (47⋅1) 316 (45⋅6) 199 (39⋅8) 0⋅027
F 604 (52⋅6) 377 (54⋅4) 301 (60⋅2)
Missing 3 (0⋅3) 0 (0) 0 (0)
CCI score* 3⋅6(6⋅4) 3⋅3(6) 3⋅1(5⋅8) 0⋅353‡
Nutritional Risk Index Low risk 604 (52⋅6) 339 (48⋅9) 270 (54⋅0) 0⋅005
Moderate risk 327 (28⋅5) 246 (35⋅5) 165 (33⋅0)
Severe risk 60 (5⋅2) 37 (5⋅3) 21 (4⋅2)
Missing 157 (13⋅7) 71 (10⋅2) 44 (8⋅8)
Accommodation before admission Own home 1114 (97⋅0) 681 (98⋅3) 492 (98⋅4) 0⋅208
Residential home 8 (0⋅7) 4 (0⋅6) 3 (0⋅6)
Nursing home 25 (2⋅2) 6 (0⋅9) 5 (1⋅0)
Missing 1 (0⋅1) 2 (0⋅3) 0 (0)
Source of referral Emergency department 807 (70⋅3) 480 (69⋅3) 312 (62⋅4) 0⋅018
General practice 197 (17⋅2) 132 (19⋅0) 106 (21⋅2)
Clinic admission 12 (1⋅0) 14 (2⋅0) 11 (2⋅2)
Referral from inpatient team 132 (11⋅5) 66 (9⋅5) 71 (14⋅2)
Missing 0 (0) 1 (0⋅1) 0 (0)
AKI on admission No 951 (82⋅8) 500 (72⋅2) 382 (76⋅4) < 0⋅001
Yes 197 (17⋅2) 192 (27⋅7) 117 (23⋅4)
Missing 0 (0) 1 (0⋅1) 1 (0⋅2)
Admission white cell count (×109/l) <11⋅9 665 (57⋅9) 363 (52⋅4) 302 (60⋅4) 0⋅052
12⋅0–15⋅9 283 (24⋅7) 193 (27⋅8) 126 (25⋅2)
>16⋅0 200 (17⋅4) 136 (19⋅6) 72 (14⋅4)
Missing 0 (0) 1 (0⋅1) 0 (0)
Radiology performed No imaging 7 (0⋅6) 17 (2⋅5) 4 (0⋅8) < 0⋅001
AXR only 297 (25⋅9) 98 (14⋅1) 31 (6⋅2)
CT only 136 (11⋅8) 148 (21⋅4) 54 (10⋅8)
CT and AXR 708 (61⋅7) 429 (61⋅9) 411 (82⋅2)
Missing 0 (0) 1 (0⋅1) 0 (0)
Oral or rectal water-soluble contrast agent No 822 (71⋅6) 653 (94⋅2) 358 (71⋅6) < 0⋅001
Yes 324 (28⋅2) 39 (5⋅6) 142 (28⋅4)
Missing 2 (0⋅2) 1 (0⋅1) 0 (0)
Operative approach Laparoscopic – 57 (8⋅2) 39 (7⋅8) < 0⋅001§
Laparoscopic converted to open – 41 (5⋅9) 37 (7⋅4)
Open – groin – 85 (12⋅3) 11 (2⋅2)
Open – midline – 451 (65⋅1) 389 (77⋅8)
Open – other – 42 (6⋅1) 22 (4⋅4)
Missing – 17 (2⋅5) 2 (0⋅4)
Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.). CCI, Charlson Co-morbidity Index; AKI, acute kidney injury;
AXR, abdominal X-ray. †χ2 test, except ‡Kruskal–Wallis test and §two-sample χ2 test across operated groups only.
summary of SBO aetiology is provided in Table S1 (sup-
porting information). Histograms of aetiology and man-
agement strategy by age (as malignancy becomes more
common) are shown in Fig. 2. Adhesive SBO affected all
ages. Hernia and malignancy were common causes of SBO
in older patients. Of 1193 patients (51⋅0 per cent) who had
an operation, 693 (29⋅6 per cent of all included patients) did
so immediately, with a further 500 (21⋅4 per cent) requiring
delayed surgery. AKI was documented in 21⋅6 per cent of
patients at admission. It was more common in patients who
underwent immediate surgery (27⋅7 per cent) than among
those who underwent delayed (23⋅4 per cent) or no (17⋅2
per cent) surgery.
Clinical outcomes
The overall mortality rate was 6⋅6 per cent (154 of 2341),
with no significant differences between treatment groups
(Table 2). The relationship between time to surgery and
death, stratified by age and co-morbidity, is presented in
Fig. 3. The overall rate of unplanned high-dependency unit
or ICU admission was 9⋅9 per cent (232 of 2431). This
was highest in the group undergoing delayed surgery (14⋅7
per cent for immediate versus 20⋅6 per cent for delayed).
The rate of major complications (unplanned critical care
admission, reoperation or death) was 14⋅4 per cent over-
all, 19⋅0 per cent in the immediate surgery, 23⋅6 per cent
in the delayed surgery and 7⋅7 per cent in non-operative
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Fig. 2 Histograms showing causes of small bowel obstruction grouped by management strategy. aNon-operative, b immediate surgery
and c delayed surgery
management groups (P< 0⋅001). Patients in the delayed
surgery group fared worse overall, with higher rates of
infective, surgical and other complications than the other
treatment groups. They had a significantly longer duration
of hospital stay compared with the immediate surgery and
non-operative groups (mean(s.d.) 18⋅6(15⋅0), 12⋅7(12⋅1)
and 7⋅3(10⋅5) days respectively) (Table 2).
Surgical intervention
The median time to surgery was 1 (i.q.r. 0–1) in the imme-
diate surgery group and 3 (2–6) days in the delayed surgery
group. A summary of procedures performed is reported
in Table S2 (supporting information). Small bowel resec-
tion was more frequent in the immediate surgery group
(34⋅8 versus 17⋅8 per cent; P< 0⋅001). A groin approach was
more common in the immediate surgery group (12⋅3 versus
2⋅2 per cent) as hernias were more frequent in this cate-
gory. Laparoscopic intervention was attempted in 14⋅1 per
cent of immediate operations and 15⋅1 per cent of delayed
operations, of which 42 and 49 per cent respectively were
converted to open procedures.
Use of diagnostic tests
All but 28 patients underwent diagnostic imaging; 80⋅6 per
cent underwent abdominal CT, and 66⋅1 per cent had both
abdominal X-ray and CT (Table 1). The mean(s.d.) interval
from CT to surgery was 2⋅4(13⋅2) days. CT was used
less in the non-operative group than the immediate and
delayed surgery groups (73⋅5, 83⋅3 and 93⋅0 respectively).
Water-soluble contrast studies (independent of CT) were
used in 21⋅6 per cent of patients overall, with differences
observed between aetiologies: they were used in 356 of
1150 patients (31⋅0 per cent) with adhesive obstruction, 35
of 415 (8⋅4 per cent) with hernia and 20 of 167 (12⋅0 per
cent) with malignant obstruction.
Nutritional management
At the time of admission, 36⋅6 per cent of patients were
stratified as being atmoderate or severe risk ofmalnutrition
according to the NRI (Table 1). Overall, 331 patients (14⋅1
per cent) received parenteral nutrition, although this was
significantly more likely in those who underwent surgery
(immediate surgery: 107 of 693, 15⋅4 per cent; delayed
surgery: 162 of 500, 32⋅4 per cent; non-operative: 62 of
1148, 5⋅4 per cent; P< 0⋅001). Patients in the delayed oper-
ation group were significantly more likely not to receive
enteral nutrition for more than 5 days than those in the
other treatment groups (delayed surgery: 351 of 500, 70⋅2
per cent; immediate surgery: 267 of 693, 38⋅5 per cent;
non-operative: 249 of 1148, 21⋅7 per cent; P< 0⋅001).
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Table 2 Outcomes after small bowel obstruction
Non-operative
(n=1148)
Immediate surgery
(n=693)
Delayed surgery
(n=500) P†
Major complications
30-day mortality No 1071 (93⋅3) 644 (92⋅9) 463 (92⋅6) 0⋅911
Yes 73 (6⋅4) 47 (6⋅8) 34 (6⋅8)
Missing 4 (0⋅3) 2 (0⋅3) 3 (0⋅6)
Any major complication No 1050 (91⋅5) 554 (79⋅9) 377 (75⋅4) <0⋅001
Yes 88 (7⋅7) 132 (19⋅0) 118 (23⋅6)
Missing 10 (0⋅9) 7 (1⋅0) 5 (1⋅0)
Reoperation No – 652 (94⋅1) 467 (93⋅4) 0⋅613‡
Yes – 33 (4⋅8) 29 (5⋅8)
Missing – 8 (1⋅2) 4 (0⋅8)
Unplanned high-dependency or ICU
admission
No 1114 (97⋅0) 582 (84⋅0) 392 (78⋅4) < 0⋅001
ICU 17 (1⋅5) 60 (8⋅7) 58 (11⋅6)
High-dependency care 10 (0⋅9) 42 (6⋅1) 45 (9⋅0)
Missing 7 (0⋅6) 9 (1⋅3) 5 (1⋅0)
Infectious complications
Urinary tract infection No 1105 (96⋅3) 648 (93⋅5) 452 (90⋅4) < 0⋅001
Not urinary catheter-associated 31 (2⋅7) 19 (2⋅7) 26 (5⋅2)
Urinary catheter-associated 10 (0⋅9) 18 (2⋅6) 18 (3⋅6)
Missing 2 (0⋅2) 8 (1⋅2) 4 (0⋅8)
Lower respiratory tract infection No 1046 (91⋅1) 592 (85⋅4) 413 (82⋅6) <0⋅001
Yes 100 (8⋅7) 94 (13⋅6) 84 (16⋅8)
Missing 2 (0⋅2) 7 (1⋅0) 3 (0⋅6)
Surgical complications/events
Deep surgical-site infection No – 650 (93⋅8) 459 (91⋅8) < 0⋅001‡
Yes – 35 (5⋅1) 38 (7⋅6)
Missing – 8 (1⋅2) 3 (0⋅6)
Superficial surgical-site infection No – 616 (88⋅9) 426 (85⋅2) 0⋅053‡
Yes – 69 (10⋅0) 71 (14⋅2)
Missing – 8 (1⋅2) 3 (0⋅6)
Abdominal wall dehiscence No – 671 (96⋅8) 472 (94⋅4) 0⋅039‡
Yes – 14 (2⋅0) 23 (4⋅6)
Missing – 8 (1⋅2) 5 (1⋅0)
Anastomotic leak No – 678 (97⋅8) 485 (97⋅0) 0⋅051‡
Yes – 6 (0⋅9) 12 (2⋅4)
Missing – 9 (1⋅3) 3 (0⋅6)
Small bowel resection No small bowel resection – 434 (62⋅6) 407 (81⋅4) < 0⋅001‡
Small bowel resection – 242 (34⋅9) 89 (17⋅8)
Missing – 17 (2⋅5) 4 (0⋅8)
Other complications
Venous thromboembolism (PE or DVT) No 1138 (99⋅1) 676 (97⋅5) 485 (97⋅0) 0⋅002
Yes 7 (0⋅6) 8 (1⋅2) 12 (2⋅4)
Missing 3 (0⋅3) 9 (1⋅3) 3 (0⋅6)
Radiologically guided drainage No 1135 (98⋅9) 674 (97⋅3) 485 (97⋅0) 0⋅018
Yes 10 (0⋅9) 11 (1⋅6) 12 (2⋅4)
Missing 3 (0⋅3) 8 (1⋅2) 3 (0⋅6)
Delirium No 1118 (97⋅4) 639 (92⋅2) 458 (91⋅6) < 0⋅001
Yes 27 (2⋅4) 47 (6⋅8) 39 (7⋅8)
Missing 3 (0⋅3) 7 (1⋅0) 3 (0⋅6)
Cardiovascular event (MI, new heart block,
stroke, TIA)
No 1101 (95⋅9) 636 (91⋅8) 453 (90⋅6) < 0⋅001
Yes 42 (3⋅7) 49 (7⋅1) 44 (8⋅8)
Missing 5 (0⋅4) 8 (1⋅2) 3 (0⋅6)
Readmission within 30days No 940 (81⋅9) 590 (85⋅1) 426 (85⋅2) 0⋅001
Yes 187 (16⋅3) 77 (11⋅1) 56 (11⋅2)
Missing 21 (1⋅8) 26 (3⋅8) 18 (3⋅6)
Duration of hospital stay (days)* 7⋅3(10⋅5) 12⋅7(12⋅1) 18⋅6(15⋅0) <0⋅001§
Time with no enteral intake (days) <5 808 (70⋅4) 378 (54⋅5) 106 (21⋅2) < 0⋅001
≥ 5 249 (21⋅7) 267 (38⋅5) 351 (70⋅2)
Missing 91 (7⋅9) 48 (6⋅9) 43 (8⋅6)
Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.). PE, pulmonary embolism; DVT, deep vein thrombosis; MI,
myocardial infarction; TIA, transient ischaemic attack. †χ2 test, except ‡two-sample χ2 test across operated groups only and §Kruskal–Wallis test.
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Factors associated with mortality
In multivariable analysis, operative management was asso-
ciated with a significantly lower hazard of death, regard-
less of whether surgery was immediate or delayed (Table 3).
An unadjusted survival curve showed comparable survival
up to day 10 (Fig. 4). Beyond this point, patients in the
non-operative group were significantly more likely to die
(P< 0⋅001). The hazard of death rose with age (Fig. 3), and
this persisted when adjusted for other variables (Table 3).
Patients treated for hernia (HR 1⋅96, 95 per cent c.i. 1⋅16
to 3⋅31; P= 0⋅012) or malignancy (HR 2⋅54, 1⋅46 to 4⋅41;
P= 0⋅001) had significantly worse survival than patients
with adhesional SBO (reference group). Patients with poor
nutritional status were significantly less likely to survive,
even after adjustment (moderate nutritional risk: adjusted
HR 1⋅55, 1⋅01 to 2⋅39, P= 0⋅045; severe nutritional risk:
adjusted HR 2⋅13, 1⋅16 to 3⋅91; P= 0⋅015). Timing of CT,
AKI at admission, accommodation before admission, sex
and CCI were not adversely associated with survival fol-
lowing multivariable adjustment.
Factors associated with major complications
Major complications (unplanned critical care admission,
reoperation or death) were reported in 14⋅4 per cent
of patients. Factors associated with a higher rate of major
complications included any form of operative management
(immediate surgery: adjusted OR 3⋅25, 95 per cent c.i. 2⋅19
to 4⋅82; P< 0⋅001; delayed surgery: adjusted OR 3⋅32, 2⋅25
to 3⋅89; P< 0⋅001). Patients with SBO secondary to malig-
nancy were more likely to develop major complications
than patients with other causes of SBO (malignancy versus
adhesions: univariable OR 2⋅35, 1⋅55 to 3⋅51; P< 0⋅001).
This effect persisted after adjustment (multivariable OR
1⋅69, 1⋅03 to 2⋅78; P= 0⋅039). A similar effect was noted
with the presence of AKI on admission (adjusted OR 1⋅41,
1⋅00 to 1⋅97; P= 0⋅048). Poor nutritional status was signif-
icantly associated with higher odds of major complications
(moderate risk of malnutrition: adjusted OR 1⋅91, 1⋅37 to
2⋅66; P< 0⋅001; severe risk: adjusted OR 3⋅41, 1⋅95 to 5⋅98;
P< 0⋅001).
Discussion
Acute admission with SBO was associated with substantial
mortality (6⋅6 per cent) and a considerable risk of major
complications (14⋅4 per cent). Patients had high rates
of AKI (21⋅6 per cent) and many were at risk of moder-
ate or severe malnutrition (36⋅6 per cent). Another key
finding was substantial variation in the use of diagnos-
tic imaging and nutritional interventions, as well as in
the timing of surgery where this took place.Morbidity rates
were higher in patients undergoing either immediate or
delayed surgery owing to the absence of surgery-associated
complications in patients managed conservatively. Factors
associated with adverse outcomes included increasing age,
AKI, moderate to severe risk of malnutrition on admission,
and hernia or malignancy as causes of SBO.
NASBO reports data captured in a prospectively devel-
oped database, with independent validation on a national
cohort of patients with SBO. The study covered all sizes
and types of hospital in the UK National Health Service
that provided acute surgical services. In contrast to other
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Table 3 Predictors of survival after small bowel obstruction
Univariable analysis* Multivariable analysis*
Hazard ratio P Hazard ratio P
Final treatment group
Non-operative 1⋅00 (reference) 1⋅00 (reference)
Immediate surgery 0⋅60 (0⋅42, 0⋅88) 0⋅008 0⋅54 (0⋅35, 0⋅85) 0⋅008
Delayed surgery 0⋅37 (0⋅24, 0⋅57) < 0⋅001 0⋅37 (0⋅23, 0⋅59) < 0⋅001
Age at admission to study (per year) 1⋅05 (1⋅03, 1⋅06) < 0⋅001 1⋅05 (1⋅03, 1⋅06) < 0⋅001
Sex
M 1⋅00 (reference) 1⋅00 (reference)
F 0⋅89 (0⋅64, 1⋅22) 0⋅465 1⋅10 (0⋅74, 1⋅64) 0⋅637
CCI score (per point) 1⋅04 (1⋅02, 1⋅07) < 0⋅001 1⋅01 (0⋅99, 1⋅04) 0⋅316
Admission white cell count (×109/l)
<11⋅9 1⋅00 (reference) 1⋅00 (reference)
12⋅0–15⋅9 1⋅03 (0⋅68, 1⋅55) 0⋅900 1⋅06 (0⋅63, 1⋅78) 0⋅832
>16⋅0 1⋅82 (1⋅24, 2⋅67) 0⋅002 1⋅67 (1⋅04, 2⋅67) 0⋅033
Accommodation before admission
Own home 1⋅00 (reference) 1⋅00 (reference)
Residential home 1⋅31 (0⋅32, 5⋅28) 0⋅708 0⋅89 (0⋅16, 5⋅09) 0⋅898
Nursing home 1⋅46 (0⋅54, 3⋅96) 0⋅452 0⋅55 (0⋅16, 1⋅90) 0⋅346
Aetiology
Adhesions 1⋅00 (reference) 1⋅00 (reference)
Crohn’s disease 0⋅18 (0⋅02, 1⋅30) 0⋅089 0⋅47 (0⋅06, 3⋅61) 0⋅467
Hernia 1⋅94 (1⋅28, 2⋅95) 0⋅002 1⋅96 (1⋅16, 3⋅31) 0⋅012
Malignancy 2⋅22 (1⋅39, 3⋅57) 0⋅001 2⋅54 (1⋅46, 4⋅41) 0⋅001
Other 1⋅01 (0⋅61, 1⋅67) 0⋅968 0⋅88 (0⋅51, 1⋅52) 0⋅650
Timing of CT (h after admission)
No CT 1⋅00 (reference) 1⋅00 (reference)
<24 0⋅91 (0⋅54, 1⋅53) 0⋅727 1⋅07 (0⋅62, 1⋅85) 0⋅810
24–48 0⋅51 (0⋅20, 1⋅29) 0⋅155 0⋅80 (0⋅32, 2⋅00) 0⋅627
>48 1⋅10 (0⋅61, 2⋅00) 0⋅746 1⋅17 (0⋅63, 2⋅17) 0⋅629
Nutritional Risk Index
Low risk 1⋅00 (reference) 1⋅00 (reference)
Moderate risk 1⋅81 (1⋅24, 2⋅65) 0⋅002 1⋅55 (1⋅01, 2⋅39) 0⋅045
Severe risk 2⋅26 (1⋅29, 3⋅96) 0⋅004 2⋅13 (1⋅16, 3⋅91) 0⋅015
AKI on admission
No 1⋅00 (reference) 1⋅00 (reference)
Yes 1⋅72 (1⋅23, 2⋅39) 0⋅001 1⋅38 (0⋅89, 2⋅13) 0⋅145
Source of referral
Emergency department 1⋅00 (reference) –
General practice 0⋅89 (0⋅57, 1⋅39) 0⋅609 –
Clinic admission 0⋅35 (0⋅05, 2⋅50) 0⋅294 –
Referral from inpatient team 1⋅12 (0⋅74, 1⋅69) 0⋅601 –
Values in parentheses are 95 per cent confidence intervals. CCI, Charlson Co-morbidity Index; AKI, acute kidney injury. *Cox proportional hazards
analysis.
reports, the present study provides comparable data on
patients who did not undergo surgery. Inclusion of data
on nutritional status and interventions represented a novel
addition. The study was strengthened by high data accu-
racy at 92⋅4 per cent.
The major limitation of the present study is its obser-
vational design, and associations identified cannot imply
causative relationships. The timing of the snapshot may
not be representative of year-round practice, and data may
be lacking on patients with SBO managed by services
other than surgery. Participation in NASBOwas voluntary.
Although coverage was broad, omission of data from the
few non-participating hospitals may also have introduced
bias. A less obvious but important limitation was the lack of
information on resources that may influence service provi-
sion and patient outcomes. This information was collected
but is not reported in this patient-level analysis. Survey
work on decision-making has been investigated as part of
NASBO and by others21,22. This may be particularly rel-
evant where surgery was deliberately deferred in an effort
to avoid operation in a particularly high-risk patient. Fur-
thermore, the need to combine heterogeneous data into
categories for analysis requires careful consideration when
interpreting the data. For example, malignant causes of
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SBO included patients with potentially curable obstruct-
ing primary tumours and those with multilevel obstruction
from disseminated cancer.
The present study shares the national reach of NELA
but, unlike NELA, provided comprehensive coverage of
patients who did not undergo surgery. Recent analysis of
NELA outcomes in patients undergoing surgical inter-
vention for adhesive SBO reported 30-day mortality at
a very similar level of 7⋅2 per cent, with risk of death
associated with increasing age, co-morbidity, outcome pre-
diction score and degree of contamination at surgery. It
also demonstrated the negative association between sur-
vival and delayed surgery23.
The present findings indicate higher rates of mortality
than those from two major recent international retrospec-
tive cohort studies looking at both operated and conserva-
tively managed patients. AnNSQIP study10 that included a
subset of patients with all-cause SBO at 13 voluntary USA
and Canadian institutions reported lower unadjusted mor-
tality rates of 3⋅3 per cent in operated patients and 4⋅5 per
cent in the non-operative group10. Another recentmultina-
tional retrospective study24 limited to four centres reported
a mortality rate of just 2 per cent across both operated and
non-operated patients with adhesive SBO; however, the
primary objective of that study was retrospective validation
of a proposed risk prediction tool and it may have been sub-
ject to selection bias24. Both studies had non-surgery rates
exceeding 60 per cent10,24.
Around half of patients with SBO (49⋅0 per cent) were
managed successfully with a conservative approach, with
comparable mortality rates to the operated groups and
fewer short-term complications. Patients in the immediate
surgery group had evidence of higher levels of organ
failure on admission and a trend towards greater sys-
temic inflammatory response, suggesting a sicker patient
group. This group appeared to have better outcomes than
the less unwell group who underwent delayed surgery for
non-resolving SBO. Potential explanations for these obser-
vations are complex. Early intervention and source control
in the immediate surgery group, deteriorating physiolog-
ical and nutritional status in the delayed surgery group,
and clinical bias in deferring surgery in unfit patients
may all have contributed21. This complexity has important
implications for both surgical decision-making and patient
counselling, making a strong case for involvement of peri-
operative anaesthetic, critical care and elderly care clini-
cians in best advising high-risk patients.
This study suggests that delayed surgery is associated
with worse outcomes for patients with SBO23,25. There are
mitigating factors that may result in deferral of surgery,
including need for preoperative resuscitation, likelihood of
successful conservative management, anticipated complex-
ity of surgery (such adhesiolysis within a hostile abdomen
or in association with complex abdominal wall hernias),
significant pre-existing co-morbidity or frailty, need for
prolonged critical care admission, minimal chances of dis-
charge from hospital and/or need for long-term escalation
in social care needs. None of these are captured as part of
this study and all may contribute to outcome.
There is scope for improvement in care throughout the
patient pathway. Approximately one in ten patients was
referred from an inpatient hospital ward. It is important
that placement within the appropriate specialty occurs
promptly to facilitate early expert review5. There was also
considerable variation in the use of imaging, with many
patients assessed with both abdominal radiography and
CT. Consultant surgeons emphasize the need for assess-
ment CT (radiation dose 7⋅9mSv in a modern multislice
CT scanner26) to guide treatment decisions and timing of
interventions22, with CT rendering an additional abdomi-
nal radiograph (potentially an additional radiation exposure
of around 0⋅7 mSV) redundant27. Patients undergoing
initial conservative management of adhesive SBO could
receive water-soluble contrast agents to stratify whether or
not the obstruction is likely to resolve without surgery28.
Although many surgeons report that they would consider
this test22, only 21⋅6 per cent of patients received it in the
present study. Barriers to the adoption of water-soluble
contrast in managing patients with adhesive SBO require
further investigation.
Optimization of the patient with SBO should also con-
sider strategies to prevent or mitigate complications29. Due
recognition should be given to the fact that patients with
SBO already have gut failure30, and prevention of further
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Table 4 Predictors of major complications after small bowel obstruction
Major complications Univariable analysis‡ Multivariable analysis§
No Yes Odds ratio* P Odds ratio* P
Final treatment group
Non-operative 1050 (53⋅0) 88 (26⋅0) 1⋅00 (reference) 1⋅00 (reference)
Immediate surgery 554 (28⋅0) 132 (39⋅1) 2⋅84 (2⋅13, 3⋅80) < 0⋅001 3⋅25 (2⋅19, 4⋅82) < 0⋅001
Delayed surgery 377 (19⋅0) 118 (34⋅9) 3⋅73 (2⋅77, 5⋅05) < 0⋅001 3⋅32 (2⋅25, 4⋅89) < 0⋅001
Age at admission to study (years) 65⋅9(17⋅0)† 73⋅4(14⋅6)† 1⋅03 (1⋅02, 1⋅04) < 0⋅001 1⋅03 (1⋅02, 1⋅04) < 0⋅001
Sex
M 899 (45⋅4) 148 (43⋅8) 1⋅00 (reference) 1⋅00 (reference)
F 1079 (54⋅6) 190 (56⋅2) 1⋅07 (0⋅85, 1⋅35) 0⋅570 1⋅07 (0⋅79, 1⋅44) 0⋅664
CCI score 3⋅2(5⋅9)† 4⋅8(7⋅2)† 1⋅04 (1⋅02, 1⋅06) < 0⋅001 1⋅02 (1⋅00, 1⋅04) 0⋅117
Admission white cell count (×109/l)
<11⋅9 1126 (56⋅8) 191 (56⋅5) 1⋅00 (reference) 1⋅00 (reference)
12⋅0–15⋅9 510 (25⋅7) 86 (25⋅4) 0⋅99 (0⋅75, 1⋅30) 0⋅966 0⋅96 (0⋅67, 1⋅36) 0⋅808
>16⋅0 345 (17⋅4) 61 (18⋅0) 1⋅04 (0⋅76, 1⋅42) 0⋅795 0⋅96 (0⋅64, 1⋅45) 0⋅847
Accommodation before admission
Own home 1938 (97⋅9) 328 (97⋅0) 1⋅00 (reference) –
Residential home 12 (0⋅6) 3 (0⋅9) 1⋅48 (0⋅34, 4⋅68) 0⋅547 –
Nursing home 29 (1⋅5) 7 (2⋅1) 1⋅43 (0⋅57, 3⋅10) 0⋅404 –
Aetiology
Adhesions 1015 (54⋅3) 126 (40⋅6) 1⋅00 (reference) 1⋅00 (reference)
Crohn’s disease 98 (5⋅2) 6 (1⋅9) 0⋅49 (0⋅19, 1⋅06) 0⋅101 0⋅82 (0⋅32, 2⋅11) 0⋅675
Hernia 346 (18⋅5) 66 (21⋅3) 1⋅54 (1⋅11, 2⋅11) 0⋅009 0⋅91 (0⋅59, 1⋅40) 0⋅661
Malignancy 130 (7⋅0) 38 (12⋅3) 2⋅35 (1⋅55, 3⋅51) < 0⋅001 1⋅69 (1⋅03, 2⋅78) 0⋅039
Other 281 (15⋅0) 74 (23⋅9) 2⋅12 (1⋅54, 2⋅90) < 0⋅001 1⋅20 (0⋅80, 1⋅81) 0⋅374
Timing of CT (h after admission)
No CT 421 (21⋅7) 27 (8⋅1) 1⋅00 (reference) 1⋅00 (reference)
<24 1229 (63⋅5) 230 (69⋅1) 2⋅92 (1⋅96, 4⋅51) < 0⋅001 1⋅91 (1⋅14, 3⋅20) 0⋅014
24–48 108 (5⋅6) 15 (4⋅5) 2⋅17 (1⋅09, 4⋅16) 0⋅023 1⋅44 (0⋅62, 3⋅34) 0⋅396
>48 178 (9⋅2) 61 (18⋅3) 5⋅34 (3⋅32, 8⋅80) < 0⋅001 3⋅47 (1⋅88, 6⋅38) < 0⋅001
Nutritional Risk Index
Low risk 1076 (61⋅3) 129 (43⋅0) 1⋅00 (reference) 1⋅00 (reference)
Moderate risk 596 (33⋅9) 137 (45⋅7) 1⋅92 (1⋅48, 2⋅49) < 0⋅001 1⋅91 (1⋅37, 2⋅66) < 0⋅001
Severe risk 84 (4⋅8) 34 (11⋅3) 3⋅38 (2⋅16, 5⋅19) < 0⋅001 3⋅41 (1⋅95, 5⋅98) < 0⋅001
AKI on admission
No 1601 (80⋅8) 215 (63⋅8) 1⋅00 (reference) 1⋅00 (reference)
Yes 380 (19⋅2) 122 (36⋅2) 2⋅39 (1⋅86, 3⋅06) < 0⋅001 1⋅41 (1⋅00, 1⋅97) 0⋅048
Source of referral
Emergency department 1362 (68⋅8) 224 (66⋅3) 1⋅00 (reference) –
General practice 379 (19⋅1) 52 (15⋅4) 0⋅83 (0⋅60, 1⋅14) 0⋅271 –
Clinic admission 34 (1⋅7) 3 (0⋅9) 0⋅54 (0⋅13, 1⋅51) 0⋅304 –
Referral from inpatient team 206 (10⋅4) 59 (17⋅5) 1⋅74 (1⋅25, 2⋅39) 0⋅001 –
Values in parentheses are percentages unless indicated otherwise; *values in parentheses are 95 per cent confidence intervals and †values are mean(s.d.).
CCI, Charlson Co-morbidity Index; AKI, acute kidney injury. ‡Logistic regression; §multilevel mixed-effects logistic regression. Odds ratios for age and
CCI score are shown per year and per point respectively.
compromise is essential as each additional organ failure
adds 5–10 per cent tomortality rates31. One in five patients
had evidence of AKI at the point of admission, a rate similar
to that in the overall intensive care population32.
Patients with SBO in this cohort were at a high risk
of malnutrition. National Institute for Health and Care
Excellence guidelines33 suggest initiation of parenteral
nutrition in patients who have lacked, or are likely to lack,
oral intake by mouth for 5 or more days. At present, there
is no high-quality evidence to guide nutritional strategy,
but poor nutrition in this cohort was associated with an
increased risk of major complications and death. This sug-
gests that addressing nutritional issues in patients with SBO
might improve overall patient outcomes.
Given the combination of the high incidence of SBO
as a reason for acute admission and the need for emer-
gency laparotomy with appreciable morbidity and mortal-
ity, there is a need for research interventions to improve
outcomes. Characterization of patients at risk of poor out-
comes, with risk assessment including co-morbidity, aeti-
ology, malnutrition risk and presence of AKI, is likely
to facilitate the value of specific interventions. An early
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stratification tool might identify those unlikely to recover
with non-operative management as well as those unlikely
to survive surgical intervention.
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